255 related articles for article (PubMed ID: 25525303)
1. GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis.
Zhang H; Wang W; Fang H; Yang Y; Li X; He J; Jiang X; Wang W; Liu S; Hu J; Liu A; Dahmen U; Dirsch O
Mediators Inflamm; 2014; 2014():629507. PubMed ID: 25525303
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
3. Endoplasmic reticulum stress-activated glycogen synthase kinase 3β aggravates liver inflammation and hepatotoxicity in mice with acute liver failure.
Ren F; Zhou L; Zhang X; Wen T; Shi H; Xie B; Li Z; Chen D; Wang Z; Duan Z
Inflammation; 2015; 38(3):1151-65. PubMed ID: 25630719
[TBL] [Abstract][Full Text] [Related]
4. Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice.
Xia Y; Rao J; Yao A; Zhang F; Li G; Wang X; Lu L
Eur J Pharmacol; 2012 Dec; 697(1-3):117-25. PubMed ID: 23051669
[TBL] [Abstract][Full Text] [Related]
5. Baicalein protects against polymicrobial sepsis-induced liver injury via inhibition of inflammation and apoptosis in mice.
Liu A; Wang W; Fang H; Yang Y; Jiang X; Liu S; Hu J; Hu Q; Dahmen U; Dirsch O
Eur J Pharmacol; 2015 Feb; 748():45-53. PubMed ID: 25533331
[TBL] [Abstract][Full Text] [Related]
6. Ferulic acid positively modulates the inflammatory response to septic liver injury through the GSK-3β/NF-κB/CREB pathway.
Cao L; Li Z; Yang Z; Wang M; Zhang W; Ren Y; Li L; Hu J; Sun Z; Nie S
Life Sci; 2021 Jul; 277():119584. PubMed ID: 33961853
[TBL] [Abstract][Full Text] [Related]
7. Glycogen synthase kinase-3 beta inhibitor suppresses Porphyromonas gingivalis lipopolysaccharide-induced CD40 expression by inhibiting nuclear factor-kappa B activation in mouse osteoblasts.
Die L; Yan P; Jun Jiang Z; Min Hua T; Cai W; Xing L
Mol Immunol; 2012 Aug; 52(1):38-49. PubMed ID: 22580404
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
Chen H; Yang S; Yang Z; Ma L; Jiang D; Mao J; Jiao B; Cai Z
J Cell Biochem; 2007 Dec; 102(5):1281-9. PubMed ID: 17427960
[TBL] [Abstract][Full Text] [Related]
9. GSK-3beta inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala EM; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Crit Care Med; 2005 Sep; 33(9):1903-12. PubMed ID: 16148458
[TBL] [Abstract][Full Text] [Related]
10. Glycogen synthase kinase 3beta functions to specify gene-specific, NF-kappaB-dependent transcription.
Steinbrecher KA; Wilson W; Cogswell PC; Baldwin AS
Mol Cell Biol; 2005 Oct; 25(19):8444-55. PubMed ID: 16166627
[TBL] [Abstract][Full Text] [Related]
11. Limb ischemic preconditioning protects against contrast-induced acute kidney injury in rats via phosphorylation of GSK-3β.
Liu T; Fang Y; Liu S; Yu X; Zhang H; Liang M; Ding X
Free Radic Biol Med; 2015 Apr; 81():170-82. PubMed ID: 25451640
[TBL] [Abstract][Full Text] [Related]
12. GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.
Li B; Zhang C; He F; Liu W; Yang Y; Liu H; Liu X; Wang J; Zhang L; Deng B; Gao F; Cui J; Liu C; Cai J
Cell Physiol Biochem; 2013; 32(6):1720-8. PubMed ID: 24356466
[TBL] [Abstract][Full Text] [Related]
13. S632A3, a new glutarimide antibiotic, suppresses lipopolysaccharide-induced pro-inflammatory responses via inhibiting the activation of glycogen synthase kinase 3β.
Deng H; Zhang N; Wang Y; Chen J; Shen J; Wang Z; Xu R; Zhang J; Song D; Li D
Exp Cell Res; 2012 Dec; 318(20):2592-603. PubMed ID: 22975730
[TBL] [Abstract][Full Text] [Related]
14. 6-(methylsulfinyl)hexyl isothiocyanate (6-MITC) from Wasabia japonica alleviates inflammatory bowel disease (IBD) by potential inhibition of glycogen synthase kinase 3 beta (GSK-3β).
Lohning A; Kidachi Y; Kamiie K; Sasaki K; Ryoyama K; Yamaguchi H
Eur J Med Chem; 2021 Apr; 216():113250. PubMed ID: 33691258
[TBL] [Abstract][Full Text] [Related]
15. Targeting glycogen synthase kinase-3β to prevent hyperoxia-induced lung injury in neonatal rats.
Hummler SC; Rong M; Chen S; Hehre D; Alapati D; Wu S
Am J Respir Cell Mol Biol; 2013 May; 48(5):578-88. PubMed ID: 23328640
[TBL] [Abstract][Full Text] [Related]
16. Glycogen synthase kinase-3β indirectly facilitates interferon-γ-induced nuclear factor-κB activation and nitric oxide biosynthesis.
Kai JI; Huang WC; Tsai CC; Chang WT; Chen CL; Lin CF
J Cell Biochem; 2010 Dec; 111(6):1522-30. PubMed ID: 20872791
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of GSK-3beta mediates expression of MMP-9 through ERK1/2 activation and translocation of NF-kappaB in rat primary astrocyte.
Kim SD; Yang SI; Kim HC; Shin CY; Ko KH
Brain Res; 2007 Dec; 1186():12-20. PubMed ID: 17996850
[TBL] [Abstract][Full Text] [Related]
18. Tissue kallikrein protects against pressure overload-induced cardiac hypertrophy through kinin B2 receptor and glycogen synthase kinase-3beta activation.
Li HJ; Yin H; Yao YY; Shen B; Bader M; Chao L; Chao J
Cardiovasc Res; 2007 Jan; 73(1):130-42. PubMed ID: 17137568
[TBL] [Abstract][Full Text] [Related]
19. GSK-3β inhibition protects the rat heart from the lipopolysaccharide-induced inflammation injury via suppressing FOXO3A activity.
Li Z; Zhu H; Liu C; Wang Y; Wang D; Liu H; Cao W; Hu Y; Lin Q; Tong C; Lu M; Sachinidis A; Li L; Peng L
J Cell Mol Med; 2019 Nov; 23(11):7796-7809. PubMed ID: 31503410
[TBL] [Abstract][Full Text] [Related]
20. Inhibiting glycogen synthase kinase 3beta in sepsis.
Dugo L; Collin M; Allen DA; Patel NS; Bauer I; Mervaala E; Louhelainen M; Foster SJ; Yaqoob MM; Thiemermann C
Novartis Found Symp; 2007; 280():128-42; discussion 142-6, 160-4. PubMed ID: 17380792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
